Can Peptides Cross the Blood-Brain Barrier?

The barrier is designed to exclude

Brain endothelial tight junctions, low nonspecific transport, metabolic enzymes, and efflux systems protect the central nervous system. Size, polarity, charge, and proteolysis limit passive peptide entry.

Some peptides use biological transport routes

Receptor-mediated transcytosis, adsorptive transport, carrier systems, and endogenous peptide transporters can sometimes be exploited. Brain-shuttle peptides are designed to bind transport receptors and carry cargo across.

Cell penetration is not brain penetration

A peptide that enters cultured cells may still fail to cross brain endothelium, survive circulation, distribute through tissue, or release cargo after transport.

Delivery platforms add complexity

Nanoparticles, liposomes, conjugates, intranasal systems, and focused physical methods are being studied. Each introduces new questions about targeting, toxicity, clearance, and manufacturing.

Measurement requires rigor

Apparent brain signal can reflect blood contamination, endothelial binding, or barrier disruption. Quantitative tissue methods and functional evidence are needed.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.